CT Colonography Effective, But Not Covered
American Cancer Society expresses its dissapointment that CT Colonography will not be covered by Medicare and Medicaid and says CT colonography (CTC) is as effective as optical colonoscopy for the early detection of early cancers.
Below is a comment from Otis W. Brawley, M.D., chief medical officer at the American Cancer Society, on today's announcement from the Centers for Medicare & Medicaid Services (CMS) that CT colonography (CTC) will not be covered by Medicare and Medicaid:
"I am disappointed in this decision, as randomized clinical trials clearly show CT colonography (CTC) is as effective as optical colonoscopy for the early detection of early cancers and premalignant lesions. Medicare coverage for CTC, also known as virtual colonoscopy, would have provided an additional option for colorectal cancer screening. Additional options are absolutely necessary as the supply of gastroenterologists is currently inadequate to supply optical colonoscopy to all of those who need it. It is our belief that by increasing the proportion of Americans 50 and over who get colorectal cancer screening, we could increase the number of lives saved from this devastating disease and decrease long term medical costs.
"The American Cancer Society still believes that a battery of different tests for colorectal cancer screening should be available to the American people. This includes optical colonoscopy, virtual colonoscopy, stool blood testing, as well as sigmoidoscopy."
Lack of health insurance coverage for certain types of health care procedures has become a worrying issue for the most Americans. In fact a recent survey from The Spectrum Health Value Study shows that access to health care is the number one priority for the most Americans.